维普中文期刊产品整合服务
38篇 您的检索式:作者名="Ekihiro"
    题名 作者 年代 出处 被引量
1Alcoholic liver disease: A current molecular and clinical perspective显示文摘Heavy alcohol use is the cause of alcoholic liver disease(ALD).The ALD spectrum ranges from alcoholic steatosis to steatohepatitis,fibrosis,and cirrhosis.In Western countries,approximately 50%of cirrhosis-related deaths are due to alcohol use.While alcoholic cirrhosis is no longer considered a completely irreversible condition,no effective anti-fibrotic therapies are currently available.Another significant clinical aspect of ALD is alcoholic hepatitis(AH).AH is an acute inflammatory condition that is often comorbid with cirrhosis,and severe AH has a high mortality rate.Therapeutic options for ALD are limited.The established treatment for AH is corticosteroids,which improve short-term survival but do not affect long-term survival.Liver transplantation is a curative treatment option for alcoholic cirrhosis and AH,but patients must abstain from alcohol use for 6 months to qualify.Additional effective therapies are needed.The molecular mechanisms underlying ALD are complex and have not been fully elucidated.Various molecules,signaling pathways,and crosstalk between multiple hepatic and extrahepatic cells contribute to ALD progression.This review highlights established and emerging concepts in ALD clin-icopathology,their underlying molecular mechanisms,and current and future ALD treatment options.Koichiro Ohashi Michael Pimienta Ekihiro Seki 2018Liver Research2018,2,4:15
2Toll-Like Receptor 9 Promotes Steatohepatitis by Induction of Interleukin-1β in Mice显示文摘Kouichi Miura Yuzo Kodama Sayaka Inokuchi Bernd Schnabl Tomonori Aoyama Hirohide Ohnishi Jerrold M. Olefsky David A. Brenner Ekihiro Seki 2010Gastroenterology2010,,1:3
3Role of Toll-Like Receptors and Their Downstream Molecules in the Development of Nonalcoholic Fatty Liver Disease显示文摘Kouichi Miura Ekihiro Seki Hirohide Ohnishi David A. Brenner Ian Nicholas Crispe 2011Gastroenterology Research and Practice2011,,:3
4Hepatic Stellate Cells Secrete Angiopoietin 1 That Induces Angiogenesis in Liver Fibrosis显示文摘Kojiro Taura Samuele De Minicis Ekihiro Seki Etsuro Hatano Keiko Iwaisako Christoph H. Osterreicher Yuzo Kodama Kouichi Miura Iwao Ikai Shinji Uemoto David A. Brenner 2008Gastroenterology2008,,5:3
5Current Views of Toll-Like Receptor Signaling Pathways显示文摘Masahiro Yamamoto Kiyoshi Takeda Ekihiro Seki 2010Gastroenterology Research and Practice2010,,:3
6Recent advancement of molecular mechanisms of liver fibrosis显示文摘Ekihiro Seki David A. Brenner 2015J Hepatobiliary Pancreat Sci2015,,:2
7Toll‐like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice显示文摘Kouichi Miura Ling Yang Nico van Rooijen David A. Brenner Hirohide Ohnishi Ekihiro Seki 2013Hepatology2013,,2:2
8Toll-Like Receptor Signaling and Liver Fibrosis显示文摘Tomonori Aoyama Yong-Han Paik Ekihiro Seki Ian Nicholas Crispe 2010Gastroenterology Research and Practice2010,,:2
9Role and cellu- lar source of nicotinamide adenine dinucleotide phosphate oxidase in hepatic fibrosis 显示文摘Samuele DM Ekihiro S Paik YH 2010Hepatology2010,52,4:1
10Nrf2 Activation Protects the Liver From Ischemia/Reperfusion Injury in Mice显示文摘Kazuhiro Kudoh Hiroshi Uchinami Masato Yoshioka Ekihiro Seki Yuzo Yamamoto 2014Annals of Surgery2014,,1:1
11Selective inacti- vation of NF-KB in the liver using NF-KB decoy suppresses CC14-induced liver injury and fibrosis 显示文摘GAKUHEI S YUJI I EKIHIRO S 2007Am J Physiol Gastrointest Liver Physiol2007,293,3:1
12The TLR4/TRIF-Mediated Activation of NLRP3 Inflammasome Underlies Endotoxin-Induced Liver Injury in Mice显示文摘Hiroko Tsutsui Michiko Imamura Jiro Fujimoto Kenji Nakanishi Ekihiro Seki 2010Gastroenterology Research and Practice2010,,:1
13CX3CL1‐CX3CR1 interaction prevents carbon tetrachloride‐induced liver inflammation and fibrosis in mice显示文摘Tomonori Aoyama Sayaka Inokuchi David A. Brenner Ekihiro Seki 2010Hepatology2010,,4:1
14Toll-like receptor signaling in liver regeneration,fibrosis and carcinogenesis显示文摘EKIHIRO S EEK JP JIRO F 2011Hepatol Res2011,41,:1
15Toll-Like Receptor Signaling in the Liver显示文摘Robert F. Schwabe Ekihiro Seki David A. Brenner 2006Gastroenterology2006,,6:1
16Toll-Like Receptor 3 in Liver Diseases显示文摘Shi Yin Bin Gao Ekihiro Seki 2010Gastroenterology Research and Practice2010,,:1
17Lipepelysaccharide-in-duced IL-18 secretion from murine Kuppffer cells independently of myeloid differentiation factor 88 that is critically involved in induction of production of IL-12 and IL-β显示文摘Ekihiro S Hiroko T Hiroki N 2001J Immunol2001,166,:1
18Gastric Bypass Surgery Improves Metabolic and Hepatic Abnormalities Associated With Nonalcoholic Fatty Liver Disease显示文摘Samuel Klein Bettina Mittendorfer J. Christopher Eagon Bruce Patterson LaFaine Grant Nikki Feirt Ekihiro Seki David Brenner Kevin Korenblat Jennifer McCrea 2006Gastroenterology2006,,6:1
19Transforming Growth Factor–β Signaling in Hepatocytes Promotes Hepatic Fibrosis and Carcinogenesis in Mice With Hepatocyte-Specific Deletion of TAK1显示文摘Ling Yang Sayaka Inokuchi Yoon Seok Roh Jingyi Song Rohit Loomba Eek Joong Park Ekihiro Seki 2013Gastroenterology2013,,5:1
20Selective inactivation of NF-KB in the liver using NF-KB decoy suppresses CCl4-induced liver injury and fibrosis显示文摘Gakuhei Son Yuji Iimuro Ekihiro Seki 2007Am J Physiol Gastrointest Liver Physiol2007,293,:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费